Answers are grounded in this paper and cite their sources.
Low levels of brain injury markers in blood are associated with good neurological outcome after CA. Incorporating biomarkers into neuroprognostication may help prevent premature withdrawal of life-sustaining therapy.
No takes yet. Share an insight, caveat, or question.
Moseby‐Knappe et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: